4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-23-027860
Chief Medical Officer acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HAMED KAMAL Chief Medical Officer | 2023-06-12 | Grant or award | +140,000 | 615,957 | D |
Loading xslF345X04/ownership.xml…